Is jejunostomy (surgical creation of an opening in the jejunum) a suitable treatment option for a patient with a massive hepatic (liver) hematoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Jejunostomy in Massive Hepatic Hematoma

Jejunostomy is not a treatment for massive hepatic hematoma itself, but rather a nutritional access procedure that may be considered after the hematoma has been surgically managed and the patient requires prolonged enteral nutrition support during recovery.

Understanding the Clinical Context

The question conflates two distinct clinical issues that require separate management approaches:

Immediate Management of Massive Hepatic Hematoma

Hemodynamically unstable patients with massive hepatic hematoma require immediate operative management focused on hemorrhage control, not jejunostomy placement. 1

  • Manual compression and hepatic packing represent the first-line damage control technique for major liver hemorrhage 2
  • Simultaneous intensive resuscitation with early massive transfusion protocol is essential to maintain organ perfusion 1, 2
  • Angioembolization should be employed for persistent arterial bleeding after non-hemostatic or damage control procedures 1
  • Temporary abdominal closure with synthetic mesh is recommended to prevent abdominal compartment syndrome 2

Hemodynamically stable patients without peritonitis should receive non-operative management as standard of care for liver trauma. 3

Role of Jejunostomy in Recovery Phase

Jejunostomy becomes relevant only after the hepatic hematoma has been addressed and the patient enters the recovery phase requiring nutritional support:

Feeding jejunostomy may be considered in patients with severe hepatobiliary injuries requiring complex resection and reconstruction, though jejunostomy-related complications occur in up to 7% of patients and intolerance to enteral nutrition is common. 1

When Jejunostomy Is Appropriate

The primary indication for jejunostomy in the context of major hepatobiliary trauma is:

  • As an adjunctive procedure during major upper digestive tract surgery where a complicated postoperative recovery is expected, prolonged fasting is anticipated, or the patient is in a hypercatabolic state 4
  • In patients with severe duodenopancreatic injuries requiring resection and reconstruction where delayed bowel function and obstruction are common 1
  • When total parenteral nutrition may be required in 37-75% of complex cases, jejunostomy provides an alternative enteral route 1

Critical Timing Considerations

Jejunostomy should never be performed during the acute hemorrhage control phase of massive hepatic hematoma management. The surgical priorities are:

  1. First priority: Control hemorrhage through packing, compression, or angioembolization 1, 2
  2. Second priority: Reverse the lethal triad (hypothermia, acidosis, coagulopathy) through damage control resuscitation 2
  3. Third priority: Achieve hemodynamic stability and ICU stabilization 2
  4. Only then: Consider nutritional access if prolonged recovery is anticipated

Specific Jejunostomy Techniques and Complications

If jejunostomy is ultimately indicated after hepatic hematoma management:

The Witzel longitudinal technique has the lowest complication rate at 2.1%, compared to transverse Witzel (6.6%), Roux-en-Y (21%), and needle catheter technique (1.5% with 0.14% mortality). 4

Complications to monitor include:

  • Mechanical: Tube dislocation, obstruction, migration, cutaneous or intraabdominal abscesses, enterocutaneous fistulas 4
  • Gastrointestinal: Diarrhea (2.3-6.8%), abdominal distension, nausea, vomiting 4
  • Metabolic: Hyperglycemia (29%), hypokalemia (50%), electrolyte imbalance 4

Post-Hepatic Hematoma Nutritional Strategy

Early enteral feeding should begin within 24-48 hours post-trauma if no contraindications exist. 3

The decision algorithm for nutritional access after hepatic hematoma management:

  1. If oral intake expected within 5-7 days: Nasogastric tube decompression alone 1
  2. If prolonged fasting anticipated (>7 days) with functional jejunum: Consider jejunostomy 4
  3. If jejunostomy complications occur or intolerance develops: Transition to total parenteral nutrition 1

Common Pitfall to Avoid

Do not delay definitive hemorrhage control to place a jejunostomy tube. The massive hepatic hematoma must be managed first through damage control surgery, with nutritional access decisions deferred to the stabilization phase or subsequent operations. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hepatic Packing: Procedure and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hepatic Steatosis in Post-Trauma Setting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Jejunostomy: techniques, indications, and complications.

World journal of surgery, 1999

Related Questions

Why is a Braun's jejunojejunostomy (J-J) performed during a cholecystoenterotomy?
Can a laxative be administered through a jejunostomy (jejunum ostomy) tube?
Can medications be administered through a gastrojejunostomy (gJ) tube?
How do I initiate an elemental diet in a patient with jejunostomy (JEJUNOSTOMY - surgical creation of an opening in the jejunum for nutritional support)?
Can a Jejunal (J) tube be exchanged at bedside?
What is the best management plan for a 64-year-old female patient, ex-smoker, with a history of malignant melanoma, lentigo maligno, and adenopathy, who refuses exenteration ocular and has multiple comorbidities?
What is the CHADS2 (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes mellitus, Stroke or transient ischemic attack) score for a patient with atrial fibrillation, congestive heart failure, hypertension, diabetes mellitus, and a history of stroke, presenting with dyspnea, shortness of breath, palpitations, irregular pulse, high jugular venous pressure (JVP), S3 heart sound, bi-basal crackles, tachycardia, and hypoxemia?
Is megestrol (a progestin) a suitable treatment option for a patient experiencing heavy vaginal bleeding?
What is the dosing for cyclic progestins (progestin), such as norethindrone or medroxyprogesterone, for a woman of reproductive age with menorrhagia?
What is the best treatment for a patient with contact dermatitis presenting with a pruritic rash on the legs and trunk?
What is the best management approach for an elderly male patient with hypertension and a history of heavy smoking, found to have a 4.5cm abdominal aortic aneurysm (AAA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.